By Bipartisan Letter Seeks Policy Clarity
U.S. Rep. Dina Titus, D-Nev., led a bipartisan quartet of House members who sent the president and three of his cabinet members a letter on Aug. 18 asking for greater clarity in the federal policy that moved medical cannabis and FDA-approved cannabis products under Schedule III of the Controlled Substances Act (CSA). The letter was also addressed to Attorney General Todd Blanche, who signed the Schedule III order on April 23, Health Secretary Robert Kennedy Jr.
and Treasury Secretary Scott Bessent.
Reps. Dave Joyce, R-Ohio, Ilhan Omar, D-Minn., and Greg Steube, R-Fla., also signed the letter. The group noted that the recent order marks a significant step in establishing a federal framework for state-licensed medical marijuana entities. They stated that they appreciate this development and the progress it reflects toward greater clarity in federal policy.
Specific Guidance Requests
The letter specifically requested guidance on practical questions including worker protections, patient rights, and health care coverage. It also asked for details on privacy safeguards, home cultivation, and the operation of the new DEA registration system. The lawmakers emphasized the need for consistent information to provide to their constituents.
“The order marks a significant step in establishing a federal framework for certain state-licensed medical marijuana entities to register and comply with the CSA,” the lawmakers wrote. “We appreciate this development and the progress it reflects toward greater clarity in federal policy.”
Implementation Questions
“As implementation moves forward, additional guidance would be helpful on several practical questions, including worker protections, patient rights, health care coverage, privacy safeguards, home cultivation and the operation of the new DEA registration system,” the lawmakers wrote. The administration has not yet responded to the specific questions raised in the Aug.
The House members said they looked forward to the White House officials’ continued efforts to advance clear and effective cannabis policy.
